ImmunityBio: Q2 Earnings Snapshot

Carbonatix Pre-Player Loader

Audio By Carbonatix

SAN DIEGO (AP) — SAN DIEGO (AP) — ImmunityBio, Inc. (IBRX) on Monday reported a loss of $134.6 million in its second quarter.

On a per-share basis, the San Diego-based company said it had a loss of 20 cents.

The immunotherapy company posted revenue of $1 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IBRX at https://www.zacks.com/ap/IBRX

 

Salem News Channel Today

Sponsored Links

On Air & Up Next

  • The Gunslinger Show
    3:00AM - 5:00AM
     
    The Gunslinger Show is a fun, lively and informative program on all facets of firearms and firearm safety.
     
  • The Total Financial Hour
     
    Arif M Halaby has dedicated his life to protecting people. He has transitioned   >>
     
  • The Inland Empire Answer
     
    Join Host Jennifer Horn for News and commentary that hits the bullseye for   >>
     
  • Miles Financial Show
    7:00AM - 7:30AM
     
    Billie Miles is a Partner and Co-Founder of MILES Financial Group, an asset and   >>
     
  • Spotlight on the Inland Empire
     
    An indepth look at businesses and organizations in the IE.
     

See the Full Program Guide